Procedure
Endovascular treatment of brain aneurysms
Treatment done from inside the blood vessels, through a thin tube placed in an artery. Coiling fills the aneurysm with soft metal coils. Flow diversion places a fine mesh tube in the artery to steer blood past the aneurysm.
General information, not medical advice. In an emergency call 911. Full disclaimer
What it does
"Endovascular" means inside the blood vessel. A doctor guides a thin tube (catheter) from an artery, often in the leg, up to the brain. [1] There are 2 main methods: coiling and flow diversion. [2]
When it is considered
- An aneurysm that has bled (a subarachnoid hemorrhage). Experts advise sealing it off early, preferably within 24 hours. [3]
- Selected unruptured aneurysms, when the risk of rupture seems higher than the risk of treatment. [4]
What matters most in the decision
Endovascular treatment does not open the skull. It is usually shorter and needs less anesthesia. [1] In exchange, coiled aneurysms are more likely to come back or need more treatment than clipped ones. [5] [2]
Coiling
How it works. A very thin tube is placed inside the aneurysm. Soft platinum coils are pushed through it and fill the aneurysm. This blocks blood from entering it. [1]
When it is used. It is used for burst and unruptured aneurysms. After a bleed, coiling gave better results than clipping for aneurysms in the back of the brain. [3]
Results after a bleed. In the ISAT trial, people whose aneurysms could be treated either way were more likely to be alive and independent after coiling than after clipping, at 1 year and at 10 years. [6] [7] A smaller US trial (BRAT) found no clear difference over 10 years. [5] See aneurysm clipping for details.
Risks for unruptured aneurysms. A review of 71 studies of endovascular treatment found: [8]
- About 5 out of 100 people had a poor outcome, including death, in the first month.
- Right after treatment, about 86 out of 100 aneurysms were well closed.
Risks during any repair. The aneurysm can burst during treatment in about 2 to 3 out of 100 cases. Stroke from blocked blood flow is another serious risk. [1]
Coming back and repeat treatment.
- In the same review, the aneurysm came back in about 24 out of 100 people who had follow-up scans over about 5 months to 3 years. About 9 out of 100 had a repeat treatment. [8]
- In BRAT, 20 out of 100 coiled aneurysms needed more treatment after the hospital stay. [5]
- A new bleed is more common after coiling than after clipping, but it is rare. In ISAT, it happened within 30 days in about 2 out of 100 coiled people and fewer than 1 out of 100 clipped people. [3]
Follow-up. Repeat imaging is advised to look for regrowth. Experts do not yet know the best timing or how long to keep checking. [3]
Stent-assisted coiling. For wide-necked, large, or giant aneurysms, a stent (a small mesh tube) may be placed in the artery to help hold the coils. People then need medicine that stops platelets from clumping. One review found complications in about 19 out of 100 people and death in about 2 out of 100. [1]
Flow diversion
How it works. A flow diverter is a stent with a much denser mesh than older stents. It is placed in the artery across the opening of the aneurysm. It reduces blood flow into the aneurysm, which then slowly closes off. [1] [2]
When it is used. It is used for very large aneurysms or ones that cannot be clipped or coiled. [2] The first US approval of a flow diverter, the Pipeline Embolization Device, was in 2011. It was for adults age 22 and older with large or giant wide-necked aneurysms in part of the internal carotid artery, a main artery to the brain. Later changes to the approval are listed in the record. [9] Use outside a device's approved labeling is called off-label use. After a bleed, experts advise avoiding flow diverters when coiling or clipping is possible. [3]
Results. In a trial of 107 adults with large or giant internal carotid aneurysms, about 74 out of 100 scanned aneurysms were fully closed at 6 months. By 5 years, 95 out of 100 were. [10]
Risks. A review of 29 studies (1451 people) found: [11]
- Serious harm from the procedure: about 5 out of 100
- Death from the procedure: about 4 out of 100
- Stroke from blocked blood flow: about 6 out of 100, more often with aneurysms in the back of the brain
- Bleeding around or into the brain: about 3 out of 100 each
Blood-thinning medicine. People take 2 medicines that stop platelets from clumping (aspirin and clopidogrel) for 3 to 6 months. Then aspirin is usually taken for life. [1] Do not stop these medicines on your own. Any change should come from your treating team.
Follow-up and repeat treatment. In the 107-person trial, people had scans at set times for 5 years. About 6 out of 100 aneurysms were treated again. No new bleeding or strokes were reported after 6 months. [10]
Alternatives
- Microsurgical clipping [2]
- For an unruptured aneurysm, watching it with repeat scans. Very small aneurysms may only need monitoring. [2]
Recovery and follow-up
After a bleed, recovery depends mostly on the bleed itself. See subarachnoid hemorrhage. Stopping smoking and controlling blood pressure may lower the chance that aneurysms form or grow. [1]
Recovery varies. Follow the discharge instructions from your own team.
Questions to ask
- Is coiling, flow diversion, or clipping the best fit for my aneurysm, and why?
- What is my chance that the aneurysm comes back or needs more treatment?
- Will I need blood-thinning medicine, and for how long?
- Is the device you plan to use approved for my type of aneurysm?
- What follow-up scans will I need, and for how many years?
Sources
- Cerebral Aneurysm. American Association of Neurological Surgeons. Published April 26, 2024. Open source
- Cerebral Aneurysms. National Institute of Neurological Disorders and Stroke. Published March 13, 2026. Open source
- Hoh BL, Ko NU, Amin-Hanjani S, et al. 2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023;54(7):e314-e370. Published May 22, 2023. Open source
- Wiebers DO, Whisnant JP, Huston J 3rd, et al; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362(9378):103-110. Published July 12, 2003. Open source
- Spetzler RF, McDougall CG, Zabramski JM, et al. Ten-year analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial. J Neurosurg. 2019;132(3):771-776. Published March 8, 2019. Open source
- Molyneux AJ, Kerr RSC, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms. Lancet. 2005;366(9488):809-817. Published September 3, 2005. Open source
- Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RSC. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT). Lancet. 2015;385(9969):691-697. Published February 21, 2015. Open source
- Naggara ON, White PM, Guilbert F, et al. Endovascular treatment of intracranial unruptured aneurysms: systematic review and meta-analysis of the literature on safety and efficacy. Radiology. 2010;256(3):887-897. Published September 1, 2010. Open source
- Pipeline Embolization Device (P100018). Premarket Approval database. US Food and Drug Administration. Published April 6, 2011. Open source
- Becske T, Brinjikji W, Potts MB, et al. Long-term clinical and angiographic outcomes following Pipeline Embolization Device treatment of complex internal carotid artery aneurysms: five-year results of the Pipeline for Uncoilable or Failed Aneurysms trial. Neurosurgery. 2017;80(1):40-48. Published January 1, 2017. Open source
- Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013;44(2):442-447. Published February 1, 2013. Open source